312 related articles for article (PubMed ID: 27225852)
1. MicroRNAs and liver disease.
Otsuka M; Kishikawa T; Yoshikawa T; Yamagami M; Ohno M; Takata A; Shibata C; Ishibashi R; Koike K
J Hum Genet; 2017 Jan; 62(1):75-80. PubMed ID: 27225852
[TBL] [Abstract][Full Text] [Related]
2. miRNAs in non-alcoholic fatty liver disease.
He Z; Hu C; Jia W
Front Med; 2016 Dec; 10(4):389-396. PubMed ID: 27680976
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseases.
Lamontagne J; Steel LF; Bouchard MJ
World J Gastroenterol; 2015 Jun; 21(24):7375-99. PubMed ID: 26139985
[TBL] [Abstract][Full Text] [Related]
4. The expression patterns and clinical significance of microRNAs in liver diseases and hepatocellular carcinoma.
Guo J; Friedman SL
Curr Pharm Des; 2013; 19(7):1262-72. PubMed ID: 23092345
[TBL] [Abstract][Full Text] [Related]
5. [MicroRNAs in hepatocarcinogenesis].
Lendvai G; Kiss A; Kovalszky I; Schaff Z
Orv Hetil; 2012 Jun; 153(25):978-89. PubMed ID: 22714032
[TBL] [Abstract][Full Text] [Related]
6. Role of MicroRNAs in NAFLD/NASH.
Szabo G; Csak T
Dig Dis Sci; 2016 May; 61(5):1314-24. PubMed ID: 26769057
[TBL] [Abstract][Full Text] [Related]
7. [Alterations in microRNA expression patterns in liver diseases].
Lendvai G; Kiss A; Kovalszky I; Schaff Z
Orv Hetil; 2010 Nov; 151(45):1843-53. PubMed ID: 20980222
[TBL] [Abstract][Full Text] [Related]
8. Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASH.
Wang Y; Liu Z; Zou W; Hong H; Fang H; Tong W
Biomark Med; 2015; 9(11):1189-200. PubMed ID: 26506944
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs and Nonalcoholic Steatohepatitis: A Review.
Morishita A; Oura K; Tadokoro T; Fujita K; Tani J; Kobara H; Ono M; Himoto T; Masaki T
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833930
[TBL] [Abstract][Full Text] [Related]
10. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease.
Torres JL; Novo-Veleiro I; Manzanedo L; Alvela-Suárez L; Macías R; Laso FJ; Marcos M
World J Gastroenterol; 2018 Sep; 24(36):4104-4118. PubMed ID: 30271077
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease.
Liu XL; Cao HX; Fan JG
J Dig Dis; 2016 Nov; 17(11):708-715. PubMed ID: 27628945
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
Zhang YC; Xu Z; Zhang TF; Wang YL
World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma.
Borel F; Konstantinova P; Jansen PL
J Hepatol; 2012 Jun; 56(6):1371-83. PubMed ID: 22314424
[TBL] [Abstract][Full Text] [Related]
15. Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation.
Blaya D; Coll M; Rodrigo-Torres D; Vila-Casadesús M; Altamirano J; Llopis M; Graupera I; Perea L; Aguilar-Bravo B; Díaz A; Banales JM; Clària J; Lozano JJ; Bataller R; Caballería J; Ginès P; Sancho-Bru P
Gut; 2016 Sep; 65(9):1535-45. PubMed ID: 27196584
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs Contribute to Hepatocellular Carcinoma.
Song Y; Wang F; Huang Q; Cao Y; Zhao Y; Yang C
Mini Rev Med Chem; 2015; 15(6):459-66. PubMed ID: 25807945
[TBL] [Abstract][Full Text] [Related]
17. The role of miRNAs in liver diseases: Potential therapeutic and clinical applications.
Doghish AS; Elballal MS; Elazazy O; Elesawy AE; Elrebehy MA; Shahin RK; Midan HM; Sallam AM
Pathol Res Pract; 2023 Mar; 243():154375. PubMed ID: 36801506
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA profiles in patients with chronic hepatitis B, chronic hepatitis C, primary biliary cirrhosis, autoimmune hepatitis, nonalcoholic steatohepatitis, or drug-induced liver injury.
Yamaura Y; Tatsumi N; Takagi S; Tokumitsu S; Fukami T; Tajiri K; Minemura M; Yokoi T; Nakajima M
Clin Biochem; 2017 Dec; 50(18):1034-1039. PubMed ID: 28823616
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in liver disease.
Wang XW; Heegaard NH; Orum H
Gastroenterology; 2012 Jun; 142(7):1431-43. PubMed ID: 22504185
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases.
Wang X; He Y; Mackowiak B; Gao B
Gut; 2021 Apr; 70(4):784-795. PubMed ID: 33127832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
